HighTower Advisors
ORTX

HighTower Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

HighTower Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,200
Closed -$4K – 3725
2022
Q4 		$4K Hold
1,200
– – ﹤0.01% 3230
2022
Q3 		$6K Hold
1,200
– – ﹤0.01% 3051
2022
Q2 		$7K Buy
+1,200
New +$6.77K ﹤0.01% 3100

Other funds holding ORTX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

HighTower Advisors's ORTX Position: Q1 2023 in Review

HighTower Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2023, closing a stake of 1,200 shares — an estimated $4K sold.

HighTower Advisors first reported a position in ORTX in Q2 2022 and held it in 3 quarters. The position peaked at $7K in Q2 2022. 35 funds tracked by Wall St. Rank hold ORTX as of Q1 2023.

  • HighTower Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • HighTower Advisors sold 1,200 Orchard Therapeutics plc American Depositary Shares shares in Q1 2023, an estimated $4K.
  • HighTower Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2022 and held it in 3 quarters.
  • HighTower Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $7K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2023.

Based on HighTower Advisors's 13F filing for Q1 2023, filed 12 May 2023.